Blue Note Therapeutics and OncoHealth have partnered to deliver oncology-specific mental health care.
As of Oct. 1, Medicare no longer covers telehealth visits.
OncoHealth, Blue Note Therapeutics partner to provide a digital therapeutic for cancer-related anxiety and depression
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
AccessHope has unveiled new research that demonstrates how remote expert oncology opinions can meaningfully bridge socioeconomic and geographic barriers to facilitate optimal cancer care.
We are rapidly approaching the Sept. 30 planned expiration of telemedicine coverage under Medicaid. Letting this authorization expire is short-sighted. As an oncologist, I believe there are multiple compelling, non-pandemic reasons for telemedicine to remain a permanent fixture in cancer care.
The Cancer Letter has published a number of excellent pieces lately on the importance of supporting and encouraging trainees and junior investigators during these uncertain times.
Researchers from UVA Cancer Center, the University of Virginia School of Medicine, and Inova Peterson Life with Cancer detail the many ways artificial intelligence could help ensure patients receive the support they need.
A telehealth partnership between Intermountain Health and the Tanana Chiefs Conference is bringing broad access to greatly needed cancer services due in a remote area of Fairbanks, Alaska.
